[{"AccountsPayableCurrent_0_Q3_USD":3827000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":200000000.0,"ProceedsFromContributedCapital_3_Q3_USD":129000.0,"PrepaidExpenseCurrent_0_Q3_USD":13477000.0,"PreferredStockValueOutstanding_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":136000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-825000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-114000.0,"OtherNoncashIncomeExpense_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":717000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-23000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-23000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":717000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-23000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":587000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":831000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2452000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1079000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":250000.0,"RelatedPartyTransactionAmountsOfTransaction_1_Q3_USD":400000.0,"RelatedPartyTransactionAmountsOfTransaction_3_Q3_USD":1300000.0,"RepaymentsOfNotesPayable_3_Q3_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":107447745.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":115025191.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":0.0,"StockholdersEquity_0_Q3_USD":505148000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":9.33,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":23.45,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":18.37,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":8.79,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6703576.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":1638000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":6.75,"OperatingLeaseExpense_3_Q3_USD":900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1369823.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":145157.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":8.7,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2613059.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":1074000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":4002861.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":22381000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-308216000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":69822000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":29756000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":2510089.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":115025191.0,"OperatingLeaseExpense_1_Q3_USD":300000.0,"OperatingExpenses_1_Q3_USD":41271000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-108842000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-41408000.0,"CommonStockValue_0_Q3_USD":12000.0,"CommonStockSharesOutstanding_0_Q3_shares":115109833.0,"CommonStockSharesIssued_0_Q3_shares":115109833.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockNoParValue_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":14413275.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":126857000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":527003000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":527003000.0,"AssetsCurrent_0_Q3_USD":540480000.0,"Assets_0_Q3_USD":543182000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":10250385.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":21443000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":9954000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":9954000.0,"AdditionalPaidInCapital_0_Q3_USD":812933000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":419000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":310000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":31448000.0,"AccruedBonusesCurrent_0_Q3_USD":2513000.0,"ConvertiblePreferredStockSharesReservedForFutureIssuance_0_Q3_shares":10000.0,"Depreciation_3_Q3_USD":87000.0,"EarningsPerShareBasic_1_Q3_USD":-0.36,"EarningsPerShareBasic_3_Q3_USD":-1.02,"NumberOfReportableSegments_3_Q3_segment":1.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NetIncomeLoss_1_Q3_USD":-41385000.0,"NetIncomeLoss_3_Q3_USD":-109559000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-73156000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-136000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":200129000.0,"LiabilitiesCurrent_0_Q3_USD":36354000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":543182000.0,"Liabilities_0_Q3_USD":38034000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":3809000.0,"OperatingExpenses_3_Q3_USD":108806000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":16188000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-72000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-109631000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-41385000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":38984000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11515000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":20000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.0007,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.0,"EarningsPerShareDiluted_3_Q3_USD":-1.02,"EarningsPerShareDiluted_1_Q3_USD":-0.36,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":1383000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":107447745.0,"Ticker":"IMVT","CIK":"1764013","name":"IMMUNOVANT, INC.","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20211231","fy":"2022.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20220204"}]